Immune responses following simian/human immunodeficiency virus (SHIV) challenge of rhesus macaques after human immunodeficiency virus (HIV)-1 third variable domain (V3) loop-based genetic immunization

Journal of Medical Primatology

Volumn 29, Issue 6, 2000, Pages 371-386

  Le Borgne, Sylvie ^a   Le Grand, Roger ^b   Michel, Marie Louise ^c   Vaslin, Bruno ^b   Boson, Bertrand ^b   Janvier, Geneviève ^a   Aubertin, Anne Marie ^d   Dormont, Dominique ^b   Rivière, Yves ^a,c  

^a CNRS   (France)

^b INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

^c INSTITUT PASTEUR   (France)

^d INSERM   (France)

Author keywords

CTLp; DNA vaccination; HBsAg; LDA; Memory response

Indexed keywords

PLASMID DNA; VIRUS DNA;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DNA VECTOR; HUMAN IMMUNODEFICIENCY VIRUS 1; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS ENVELOPE; VIRUS IMMUNITY; VIRUS INHIBITION;

EID: 0034496431     PISSN: 00472565     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0684.2000.290601.x     Document Type: Article

References (60)

1. Protection of MN-rgp120-immunized chimpanzees from heterologous infection with a primary isolate of human immunodeficiency virus type 1
2. Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination
3. In vivo protective anti-HIV immune responses in non-human primates through DNA immunization
4. HIV-1 envelope-elicited neutralizing antibody titres correlate with protection and virus load in chimpanzees
5. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: Differential CTL responses to HIV-1 and Epstein-Barr virus in late disease
6. Changes in human immunodeficiency virus type 1 envelope glycoproteins responsible for the pathogenicity of a multiply passaged simian-human immunodeficiency virus (SHIV-HXBc2)
7. Kinetics of primary SIV infection in lymph nodes
8. T cell receptor V beta repertoire in an acute infection of rhesus monkeys with simian immunodeficiency viruses and a chimeric simian-human immunodeficiency virus
9. Cytokine mRNA expression in mononuclear cells from different tissues during acute SIVmac251 infection of macaques
10. Molecular detection and in vivo analysis of the specific T cell response to a protein antigen
11. Isolation of T-cell tropic HTLV-III-like retrovirus from macaques
12. DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody
13. The simian immunodeficiency viruses
14. DNA vaccines
15. High viral load and CD4 lymphopenia in rhesus and cynomolgus macaques infected by a chimeric primate lentivirus constructed using the env, rev, tat, and vpu genes from HIV-1 Lai
16. + nef-specific cytotoxic T cells in vaccinated macaques
17. Vaccine-induced protection of chimpanzees against infection by a heterologous human immunodeficiency virus type 1
18. Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara boost vaccination regimen
19. Betachemokines and neutralizing antibody titers correlate with sterilizing immunity generated in HIV-1 vaccinated macaques
20. Recognition of prominent viral epitopes induced by immunization with human immunodeficiency virus type 1 regulatory genes
21. + T cell depletion in simian immunodeficiency virus-infected macaques
22. Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus
23. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome
24. Comparative analysis of cytotoxic T lymphocytes in lymph nodes and peripheral blood of simian immunodeficiency virus-infected rhesus monkeys
25. Synergistic neutralization of human immunodeficiency virus type 1 by combinations of human monoclonal antibodies
26. In vivo induction of specific cytotoxic T lymphocytes in mice and rhesus macaques immunized with DNA vector encoding an HIV epitope fused with hepatitis B surface antigen
27. Course of specific T lymphocyte cytotoxicity, plasma and cellular viral loads, and neutralizing antibody titers in 17 recently seroconverted HIV type 1-infected patients
28. Specific and non-specific immunity and protection of macaques against SIV infection
29. Immunologic and pathologic manifestations of the infection of rhesus monkeys with simian immunodeficiency virus of macaques
30. Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination
31. Limited protection from a pathogenic chimeric simian-human immunodeficiency virus challenge following immunization with attenuated simian immunodeficiency virus
32. Recombinant Mycobacterium bovis BCG producing the N-terminal half of SIVmac251 Env antigen induces neutralizing antibodies and cytotoxic T lymphocyte responses in mice and guinea pigs
33. Simian immunodeficiency virus DNA vaccine trial in macaques
34. Characterization of a polyclonal cytolytic T lymphocyte response to human immunodeficiency virus in persons without clinical progression
35. Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques
36. Detection of primary cytotoxic T lymphocytes specific for the envelope glycoprotein of HIV-1 by deletion of the env aminoterminal signal sequence
37. Immunophenotypic analysis of peripheral blood mononuclear cells undergoing in vitro apoptosis after isolation from human immunodeficiency virus-infected children
38. DNA-mediated immunization to the hepatitis B surface antigen in mice: Aspects of the humoral response mimic hepatitis B viral infection in humans
39. The Gag-specific cytotoxic T lymphocytes in rhesus monkeys infected with the simian immunodeficiency virus of macaques
40. Neutralizing antibodies in sera from macaques infected with chimeric simian-human immunodeficiency virus containing the envelope glycoproteins of either a laboratory-adapted variant or a primary isolate of human immunodeficiency virus type 1
41. Autologous and heterologous neutralizing antibody responses following initial seroconversion in human immunodeficiency virus type 1-infected individuals
42. The immunoscope approach for the analysis of T-cell repertoires
43. + T cells with a predominant V beta usage during the primary immune response to HIV
44. Immune responses but no protection against SHIV by gene-gun delivery of HIV- 1 DNA followed by recombinant subunit protein boosts
45. Protection against mucosal SIVsm challenge in macaques infected with a chimeric SIV that expresses HIV type 1 envelope
46. A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate Env causes an AIDS-like disease after in vivo passage in rhesus monkeys
47. Immunopathogenic events in acute infection of rhesus monkeys with simian immunodeficiency virus of macaques
48. High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors
49. Gag-specific cytotoxic responses to HIV type 1 are associated with a decreased risk of progression to AIDS-related complex or AIDS
50. Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA
51. Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations
52. + lymphocytosis during primary simian immunodeficiency virus infections
53. Selective stimulation of murine cytotoxic T cell and antibody responses by particulate or monomeric hepatitis B virus surface (S) antigen
54. + lymphocytes
55. Heterologous protection against influenza by injection of DNA encoding a viral protein
56. Cytotoxic T lymphocyte response against multiple simian immunodeficiency virus (SIV) proteins in SIV-infected macaques
57. Superinfection of HIV-2-preinfected macaques after rectal exposure to a primary isolate of SIVmac251
58. Oligoclonal expansions of CD8(+) T cells in chronic HIV infection are antigen specific
59. + lymphocyte response in acutely infected rhesus monkeys
60. Simian immunodeficiency virus-specific cytotoxic T-lymphocyte induction through DNA vaccination of rhesus monkeys